The unstable caratid stenasis: Definition and biological processes;Die instabile karotisstenose: Definition und pathobiologische mechanismen

Hamostaseologie

Volumn 23, Issue 2, 2003, Pages 61-66

  Sitzer, Matthias ^a   Trostdorf, F ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Arteria carotis interna; Atherosclerosis; Stroke

Indexed keywords

GELATINASE B; THROMBOPLASTIN;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL INFILTRATION; CHLAMYDOPHILA PNEUMONIAE; GENE OVEREXPRESSION; HUMAN; INFLAMMATORY CELL; INTERNAL CAROTID ARTERY OCCLUSION; MACROPHAGE; RETINA ISCHEMIA; REVIEW; RISK FACTOR; SMOOTH MUSCLE FIBER; STROKE; T LYMPHOCYTE; THROMBOGENESIS; THROMBOGENICITY;

EID: 0037599284     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619573     Document Type: Review

References (58)

1. Endarterectomy for asymptomatic carotid artery stenosis. Executive committee for the asymptomatic carotid atherosclerosis study. JAMA 1995; 273: 1421-8.
2. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the mrc european carotid surgery trial (ecst). Lancet 1998; 351: 1379-87.
3. Babikian VL, Hyde C, Pochay V et al. Clinical correlates of high-intensity transient signals detected on transcranial doppler sonography in patients with cerebrovascular disease. Stroke 1994; 25: 1570-3.
4. Ballotta E, Da Giau G, Renon L. Carotid plaque gross morphology and clinical presentation: A prospective study of 457 carotid artery specimens. J Surg Res 2000; 89: 78-84.
5. Barnett HJ, Taylor DW, Eliasziw M et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 1998; 339: 1415-25.
6. Bassiouny HS, Sakaguchi Y, Mikucki SA et al. Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg 1997; 26: 585-94.
7. Bauriedel G, Hutter R, Welsch U et al. Role of smooth muscle cell death in advanced coronary primary lesions: Implications for plaque instability. Cardiovasc Res 1999; 41: 480-8.
8. Buchkremer M, Jander S, Sitzer M et al. Expression of matrix metalloproteinase-1 in carotid artery plaque. Cerebrovasc Dis 2001; 11 (suppl 4): 104.
9. Carr S, Farb A, Pearce WH et al. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 1996; 23: 755-65.
10. Carr SC, Farb A, Pearce WH et al. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 1997; 122: 757-63.
11. Crisby M, Nordin-Fredriksson G, Shah PK et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation 2001; 103: 926-33.
12. DeGraba TJ, Siren AL, Penix L et al. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke 1998; 29: 1405-10.
13. Esposito G, Blasi F, Allegra L et al. Demonstration of viable chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann Vasc Surg 1999; 13: 421-25.
14. Fine-Edelstein JS, Wolf PA, O'Leary DH et al. Precursors of extracranial carotid atherosclerosis in the Framingham study. Neurology 1994; 44: 1046-50.
15. Galis ZS, Sukhova GK, Lark MW et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-503.
16. Galis ZS, Sukhova GK, Kranzhofer R et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995; 92: 402-6.
17. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995; 147: 251-66.
18. Goertler M, Baeumer M, Kross R et al. Rapid decline of cerebral microemboli of arterial origin after intravenous acetylsalicylic acid. Stroke 1999; 30: 66-9.
19. Golledge J, Greenhalgh RM, Davies AH. The symptomatic carotid plaque. Stroke 2000; 31: 74-81.
20. Han DK, Haudenschild CC, Hong MK et al. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995; 147: 267-77.
21. Hennerici M, Hulsbomer HB, Hefter H et al. Natural history of asymptomatic extracranial arterial disease. Results of a long-term prospective study. Brain 1987; 110: 777-91.
22. Herman MP, Sukhova GK, Kisiel W et al. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 2001; 107: 1117-26.
23. Inzitari D, Eliasziw M, Gates P et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 2000; 342: 1693-1700.
24. Isner JM, Kearney M, Bortman S et al. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703-11.
25. Jacob T, Ascher E, Hingorani A et al. Differential proteolytic activity and induction of apoptosis in fibrous versus atheromatous plaques in carotid atherosclerotic disease. J Vasc Surg 2001; 33: 614-20.
26. Jander S, Sitzer M, Schumann R et al. Inflammation in high-grade carotid stenosis: A possible role for macrophages and t cells in plaque destabilization. Stroke 1998; 29: 1625-30.
27. Jander S, Sitzer M,Wendt A et al. Expression of tissue factor in high-grade carotid artery stenosis: Association with plaque destabilization. Stroke 2001; 32: 850-4.
28. Jovinge S, Crisby M,Thyberg J et al. DNA fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler Thromb Vasc Biol 1997; 17: 2225-31.
29. Kaposzta Z, Baskerville PA, Madge D et al. L-arginine and S-nitrosoglutathione reduce embolization in humans. Circulation 2001; 103: 2371-5.
30. Kockx MM, De Meyer GR, Buyssens N et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of holesterol withdrawal. Circ Res 1998; 83: 378-87.
31. Kockx MM, Herman AG. Apoptosis in atherogenesis: Implications for plaque destabilization. Eur Heart J 1998; 19 (Suppl): G23-28.
32. Kolodgie FD, Narula J, Burke AP et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 2000; 157: 1259-68.
33. LaBiche R, Koziol D, Quinn TC et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 2001; 32: 855-60.
34. Lammie GA, Sandercock PA, Dennis MS. Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque. Stroke 1999; 30: 1319-25.
35. Lammie GA, Wardlaw J, Allan P et al. What pathological components indicate carotid atheroma activity and can these be identified reliably using ultrasound? Eur J Ultrasound 2000; 11: 77-86.
36. Loftus IM, Naylor AR, Goodall S et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 2000; 31: 40-7.
37. Mallat Z, Hugel B, Ohan J et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-53.
38. Mallat Z, Corbaz A, Scoazec A et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001; 89: E41-45.
39. Markus HS. Transcranial Doppler ultrasound. Br Med Bull 2000; 56: 378-88.
40. Molloy J, Martin JF, Baskerville PA et al. S-Nitrosoglutathione reduces the rate of embolization in humans. Circulation 1998; 98: 1372-5.
41. Molloy J, Markus HS. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 1999; 30: 1440-3.
42. Nadareishvili ZG, Koziol DE, Szekely B et al. Increased CD8(+) T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque. Stroke 2001; 32: 1966-72.
43. Ogata J, Yutani C, Kaneko T et al. Rupture of atheromatous plaque as a cause of thrombotic occlusion of the internal carotid artery. Stroke 1987; 18: 1175-6.
44. Pasterkamp G, Schoneveld AH, Hijnen DJ et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000; 150: 245-53.
45. Sacco R. Ischemic stroke, In: Gorelick P, Alter M (eds). Handbook of neuroepidemiology. New York Basel Hong Kong: Marcel Decker Inc. 1994: 77-119.
46. Siebler M, Sitzer M, Rose G et al. Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis. Event rates before and after carotid endarterectomy. Brain 1993; 116: 1005-15,
47. Siebler M, Kleinschmidt A, Sitzer M et al. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Neurology 1994; 44: 615-8.
48. Siebler M, Nachtmann A, Sitzer M et al. Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke 1995; 26: 2184-6.
49. Siebler M, Sitzer M, Rose G et al. Microembolism in carotid artery disease. Echocardiography 1996; 13: 529-36.
50. Siebler M, Junghans U, Seitz R et al. Platelet glycoprotein IIb/IIIa receptor antagonist blocked microembolism and salvaged ischemic brain tissue from infarction. Cerebrovasc Dis 2001; 11: 24.
51. Sitzer M, Muller W, Siebler M et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke 1995; 26: 1231-3.
52. Sitzer M, Siebler M, Rose G et al. Cerebral microembolism in atherosclerotic carotid artery disease: Facts and perspectives. Funct Neurol 1995; 10: 251-8.
53. Spencer MP. Doppler microembolic signals for diagnosis of ulcerated carotid artery plaques. Echocardiography 1996; 13: 551-4.
54. Stork JL, Kimura K. Levi CR et al. Source of microembolic signals in patients with highgrade carotid stenosis. Stroke 2002; 33: 2014-8.
55. Thiruvikraman SV, Guha A, Roboz J et al. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigeninlabeled factors VIIa and X. Lab Invest 1996; 75: 451-61.
56. Tremoli E,Camera M, Toschi V et al. Tissue factor in atherosclerosis. Atherosclerosis 1999; 144: 273-83.
57. , van Zuilen EV, Moll FL, Vermeulen FE et al. Detection of cerebral microemboli by means of transcranial doppler monitoring before and after carotid endarterectomy. Stroke 1995; 26: 210-3.
58. Yamashita K, Ouchi K, Shirai M et al. Distribution of chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 1998; 29: 773-8.